Prioritize, Leverage, Collaborate, Hamburg Exhorts Biotech Crowd
Executive Summary
Academics and drug developers, as well as FDA, will have to be more creative in their collaborations if they are to foster innovation in an era of inconsistent and continually eroding federal funding support, the FDA commissioner advised.